Skip to main content
. 2020 Aug 10;10:13486. doi: 10.1038/s41598-020-70351-0

Figure 1.

Figure 1

Flow chart for patient screening. A total of 132 metastatic colorectal cancer patients were genotyped for genetic polymorphisms and 66 patients who did not treated with irinotecan-based chemotherapy were excluded. Of the 66 patients treated with irinotecan-based chemotherapy were included in this analysis.